Oncogenic mutation BRAFV600E is found in up to 50% of human melanomas; mutant BRAF protein induces internalization of pMHC-I complexes and their intracellular sequestration within endo-lysosomal compartments, facilitating tumor immune evasion via reduced surface pMHC-I display [117]. Here, BRAF is linked to neoplasm.